Another edition of PCI Days 2026 has come to a close – the largest B2B trade fair for the pharmaceutical, cosmetics, and dietary supplements sectors in Central and Eastern Europe.
AJ LAW Uchańska Diskau was represented by Dr. Joanna Uchańska, who delivered a presentation on AI Compliance in the Dietary Supplements Industry. She shared not only her professional experience but also practical insights into the current challenges facing the food and dietary supplements market.
In the latest issue of “Świat Przemysłu Farmaceutycznego,” an article by attorney-at-law Joanna Uchańska, partner at AJ LAW Uchańska Diskau, entitled “Rap, Prescriptions and Legal Provisions: Can Literary Interpretation Defend Itself Before the Chief Pharmaceutical Inspector and What Does It Have to Do with Pharmaceutical Advertising?” has been published. The article is devoted to one of the most widely discussed decisions of the Chief Pharmaceutical Inspector in recent months and its potential consequences for the pharmaceutical market and contemporary marketing communication.
The week began on an intensive note for our law firm's team. As part of ongoing litigation matters, Joanna Uchańska, Attorney-at-Law and Partner at AJ LAW Uchańska Diskau, and Edyta Oleszczuk-Romańska, Attorney-at-Law at our firm, represented clients during hearings before administrative courts concerning issues in the field of food law, including food for special medical purposes (FSMPs).
On 9 June 2026, the conference of the National Council of Supplements and Nutrition (KRSiO) and the KRSiO General Assembly of Members took place. Among the participants was Dr. Joanna Uchańska, Partner at AJ LAW Uchańska Diskau and Vice-Chair of KRSiO. The event was held in Warsaw and brought together experts from the pharmaceutical industry and the dietary supplements sector.
We are pleased to announce that Dr. Joanna Uchańska, Partner at AJ LAW Uchańska Diskau, will be speaking at PCI Days 2026 – the largest B2B trade fair for the pharmaceutical, cosmetics, and dietary supplements industries in Central and Eastern Europe.
On May 27, 2026, a meeting of the Parliamentary Committee for Pro-Health Food and Nutrition took place in the Sejm of the Republic of Poland – an important forum dedicated to the future of the dietary supplement market, food safety, and directions for the development of innovation in the health & wellness industry.
The relationship between freedom of artistic expression and the restrictive provisions of pharmaceutical law has become the subject of an unprecedented ruling by supervisory authorities. In a decision dated April 2, 2026 (reference number: POWII.600.8.2026.JD.6), the Chief Pharmaceutical Inspector (GIF) assessed the work of one of the most popular Polish musical artists, concluding that the content contained therein goes beyond the framework of artistic expression and constitutes prohibited advertising of medicinal products.
For businesses operating in the trade and distribution sector, payment backlogs represent one of the key operational risks. The President of the Office of Competition and Consumer Protection (UOKiK) is systematically tightening supervision over the timeliness of B2B settlements. Ignoring warning signals from the authority may result in the initiation of formal administrative proceedings, which typically conclude with the imposition of substantial mandatory financial penalties.
In April 2026, a draft amendment to the Food Safety and Nutrition Act was published. The draft is currently undergoing the legislative process and may significantly impact businesses operating in the food sector, particularly manufacturers and distributors of food supplements.
The next edition of PCI Days 2026, one of the key events for the cosmetics and food supplement industries in Poland, is coming soon. The event serves as a platform where innovation meets business practice, bringing together experts from around the world to share knowledge, experience, and the latest market trends.
